{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:08:21Z","timestamp":1789992501297,"version":"4.0.1"},"reference-count":185,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T00:00:00Z","timestamp":1603411200000},"content-version":"am","delay-in-days":327,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Conseil R\u00e9gional de Normandie"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.ejmech.2019.111705","type":"journal-article","created":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T11:04:06Z","timestamp":1568631846000},"page":"111705","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Structure-activity relationships of serotonin 5-HT7 receptors ligands: A review"],"prefix":"10.1016","volume":"183","author":[{"given":"Sangeetha-Laura","family":"Thirumaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alban","family":"Lepailleur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7996-2082","authenticated-orcid":false,"given":"Christophe","family":"Rochais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2019.111705_bib1","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0021-9258(18)57137-4","article-title":"Serum vasoconstrictor (serotonin). IV. Isolation and characterization","volume":"176","author":"Rapport","year":"1948","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2019.111705_bib2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1152\/ajplegacy.1953.175.1.157","article-title":"Serotonin content of some mammalian tissues and urine and a method for its determination","volume":"175","author":"Twarog","year":"1953","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejmech.2019.111705_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1749-6632.1990.tb16870.x","article-title":"Anatomy of the serotonergic system","volume":"600","author":"Tork","year":"1990","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejmech.2019.111705_bib4","first-page":"4","article-title":"Awakening the sleeping giant: anatomy and plasticity of the brain serotonergic system","volume":"52","author":"Azmitia","year":"1991","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.ejmech.2019.111705_bib5","first-page":"65","article-title":"Effects of manipulation of biogenic amine levels upon spinal cord reflexes","volume":"11","author":"Wooley","year":"1968","journal-title":"Proc. West. Pharmacol. Soc."},{"key":"10.1016\/j.ejmech.2019.111705_bib6","first-page":"173","article-title":"Defects in monoamine metabolism and their possible importance in the pathogenesis of depressive syndromes","volume":"72","author":"Coppen","year":"1969","journal-title":"Psychiatr. Neurol. Neurochir."},{"key":"10.1016\/j.ejmech.2019.111705_bib7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0091-3057(94)00421-E","article-title":"Involvement of 5-HT1A receptors in the anxiolytic action of S 14671 in the pigeon conflict test","volume":"51","author":"Schreiber","year":"1995","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejmech.2019.111705_bib8","first-page":"411","article-title":"Serotonin and dopamine systems regulating alcohol intake","volume":"1","author":"McBride","year":"1991","journal-title":"Alcohol Alcohol Suppl."},{"key":"10.1016\/j.ejmech.2019.111705_bib9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0893-133X(95)00068-O","article-title":"New insights into the biology of schizophrenia through the mechanism of action of clozapine","volume":"13","author":"Brunello","year":"1995","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejmech.2019.111705_bib10","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0166-4328(94)00157-B","article-title":"The role of serotonergic-cholinergic interactions in the mediation of cognitive behavior","volume":"67","author":"Steckler","year":"1995","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejmech.2019.111705_bib11","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/374542a0","article-title":"Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors","volume":"374","author":"Tecott","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2019.111705_bib12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0006-8993(92)91580-8","article-title":"Effects of 5-HT receptor antagonists on seizure susceptibility and locomotor activity in DBA\/2 mice","volume":"588","author":"Semenova","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.ejmech.2019.111705_bib13","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.febslet.2015.05.054","article-title":"The roles of peripheral serotonin in metabolic homeostasis","volume":"589","author":"El-Merahbi","year":"2015","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejmech.2019.111705_bib14","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1021\/cn300154j","article-title":"Life without peripheral serotonin: insights from tryptophan hydroxylase 1 knockout mice reveal the existence of paracrine\/autocrine serotonergic networks","volume":"4","author":"Amireault","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2019.111705_bib15","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.tips.2008.06.009","article-title":"5-hydroxytryptamine and cardiovascular regulation","volume":"29","author":"Ramage","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2019.111705_bib16","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbr.2008.03.020","article-title":"Molecular biology of 5-HT receptors","volume":"195","author":"Hannon","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejmech.2019.111705_bib17","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1046\/j.1471-4159.1997.68041372.x","article-title":"Four 5-Hydroxytryptamine 7 (5-HT7) receptor isoforms in human and rat produced by alternative splicing: species differences due to altered intron\u2014exon organization","volume":"68","author":"Heldmann","year":"1997","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.ejmech.2019.111705_bib18","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1124\/jpet.104.081919","article-title":"Differential agonist-mediated internalization of the human 5-hydroxytryptamine 7 receptor isoforms","volume":"313","author":"Guthrie","year":"2005","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2019.111705_bib19","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0165-6147(99)01432-7","article-title":"5-HT7 receptors: current knowledge and future prospects","volume":"21","author":"Vanhoenacker","year":"2000","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2019.111705_bib20","doi-asserted-by":"crossref","first-page":"23422","DOI":"10.1016\/S0021-9258(19)49479-9","article-title":"Cloning of a novel human serotonin receptor (5 -HT7) positively linked to adenylate cyclase","volume":"268","author":"Bard","year":"1993","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2019.111705_bib21","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s002100000369","article-title":"The cloned human 5-HT7 receptor splice variants: a comparative characterization of their pharmacology, function and distribution","volume":"363","author":"Krobert","year":"2001","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.111705_bib22","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1476-5381.2009.00481.x","article-title":"Phe369(7.38) at human 5-HT7 receptors confers interspecies selectivity to antagonists and partial agonists","volume":"159","author":"Varin","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.111705_bib23","doi-asserted-by":"crossref","first-page":"5638","DOI":"10.1021\/jm030841r","article-title":"Optimization of the pharmacophore model for 5-HT7R antagonism. Design and synthesis of new naphtholactam and naphthosultam derivatives","volume":"46","author":"L\u00f3pez-Rodr\u00edguez","year":"2003","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111705_bib24","doi-asserted-by":"crossref","first-page":"6732","DOI":"10.1021\/jm060300c","article-title":"Receptor-based pharmacophores for serotonin 5-HT7R antagonists-implications to selectivity","volume":"49","author":"Kolaczkowski","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111705_bib25","doi-asserted-by":"crossref","first-page":"6879","DOI":"10.1021\/jm500880c","article-title":"The extracellular entrance provides selectivity to serotonin 5-HT7 receptor antagonists with antidepressant-like behavior in\u00a0vivo","volume":"57","author":"Medina","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111705_bib26","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ejmech.2016.07.029","article-title":"5-HT7 receptor modulators: amino groups attached to biphenyl scaffold determine functional activity","volume":"123","author":"Kim","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111705_bib27","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.1021\/jm030826m","article-title":"Characterization of the 5-HT7 receptor. Determination of the pharmacophore for 5-HT7 receptor agonism and CoMFA-based modeling of the agonist binding site","volume":"46","author":"Vermeulen","year":"2003","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111705_bib28","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1021\/jm049743b","article-title":"Novel 5-HT7 receptor inverse agonists. Synthesis and molecular modeling of arylpiperazine- and 1, 2, 3, 4-tetrahydroisoquinoline-based arylsulfonamides","volume":"47","author":"Vermeulen","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111705_bib29","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S1043-9471(05)80049-7","article-title":"Integrated methods for modeling G protein coupled receptors","volume":"25","author":"Ballesteros","year":"1996","journal-title":"Methods Neurosci."},{"key":"10.1016\/j.ejmech.2019.111705_bib30","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1021\/jm8014553","article-title":"Synthesis of new serotonin 5-HT7 receptor ligands. Determinants of 5-HT7\/5-HT1A receptor selectivity","volume":"52","author":"Medina","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111705_bib31","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1038\/sj.bjp.0704588","article-title":"The human 5-HT7 serotonin receptor splice variants: constitutive activity and inverse agonist effects","volume":"135","author":"Krobert","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.111705_bib32","doi-asserted-by":"crossref","first-page":"17469","DOI":"10.1074\/jbc.273.28.17469","article-title":"Stimulation of type 1 and type 8 Ca2+\/calmodulin-sensitive adenylyl cyclases by the Gs-coupled 5-Hydroxytryptamine subtype 5-HT7A receptor","volume":"273","author":"Baker","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2019.111705_bib33","doi-asserted-by":"crossref","first-page":"7821","DOI":"10.1523\/JNEUROSCI.1790-05.2005","article-title":"5-HT7 receptor is coupled to G\u03b1 subnits of heterodimers G12-protein to regulate gene transcription and neuronal morphology","volume":"25","author":"Kvachnina","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ejmech.2019.111705_bib34","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1111\/j.1742-4658.2005.04658.x","article-title":"Endogenous expression and protein kinase A-dependent phosphorylation of the guanine nucleotide exchange factor Ras-GRF1 in human embryonic kidney 293 cells","volume":"272","author":"Norum","year":"2005","journal-title":"FEBS J."},{"key":"10.1016\/j.ejmech.2019.111705_bib35","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.neuropharm.2012.10.026","article-title":"The serotonin receptor 7 promotes neurite outgrowth via ERK and Cdk5 signaling pathways","volume":"67","author":"Speranza","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2019.111705_bib36","first-page":"2486","article-title":"Heterodimerization of serotonin receptors 5-HT1A and 5-HT7 differentially regulates receptor signalling and trafficking","volume":"125","author":"Renner","year":"2012","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.ejmech.2019.111705_bib37","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0306-4522(00)00460-7","article-title":"5-HT(7) receptors activate the mitogen activated protein kinase extracellular signal related kinase in cultured rat hippocampal neurons","volume":"102","author":"Errico","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejmech.2019.111705_bib38","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1046\/j.1471-4159.2003.02076.x","article-title":"Coupling of neuronal 5-HT7 receptors to activation of extracellular-regulated kinase through a protein kinase A-independent pathway that can utilize Epac","volume":"87","author":"Lin","year":"2003","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.ejmech.2019.111705_bib39","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1471-4159.2004.02832.x","article-title":"Enhanced activation of Akt and extracellular-regulated kinase pathways by simultaneous occupancy of Gq-coupled 5-HT2A receptors and Gs-coupled 5-HT7A receptors in PC12 cells","volume":"92","author":"Johnson-Farley","year":"2005","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.ejmech.2019.111705_bib40","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1471-4159.2005.03079.x","article-title":"Serotonin via 5-HT7 receptors activates p38 mitogen-activated protein kinase and protein kinase C epsilon resulting in interleukin-6 synthesis in human U373 MG astrocytoma cell","volume":"93","author":"Lieb","year":"2005","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.ejmech.2019.111705_bib41","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1182\/blood-2006-10-052787","article-title":"Serotonin provides an accessory signal to enhance T-cell activation by signaling through the 5-HT7 receptor","volume":"109","author":"Leon-Ponte","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2019.111705_bib42","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.neulet.2012.01.016","article-title":"Activation of 5-HT7 receptors increases neuronal platelet-derived growth factor \u03b2 receptor expression","volume":"511","author":"Vasefi","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejmech.2019.111705_bib43","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1471-4159.2009.05918.x","article-title":"Selectivity and functional consequences of interactions of family A G protein-coupled receptors with neurochondrin and periplakin","volume":"109","author":"Ward","year":"2009","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.ejmech.2019.111705_bib44","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0022-3565(24)39121-9","article-title":"5-Hydroxytryptamine (7) receptor activation decreases slow afterhyperpolarization amplitude in CA3 hippocampal pyramidal cells","volume":"294","author":"Bacon","year":"2000","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2019.111705_bib45","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1021\/jm0104264","article-title":"2a-[4-(Tetrahydropyridoindol-2-yl)butyl]tetrahydrobenzindole derivatives: new selective antagonists of the 5-hydroxytryptamine 7 receptor","volume":"45","author":"Kikuchi","year":"2002","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111705_bib46","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0960-894X(02)00842-9","article-title":"New tetrahydrobenzindoles as potent and selective 5-HT(7) antagonists with increased in\u00a0vitro metabolic stability","volume":"13","author":"Kikuchi","year":"2003","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.111705_bib47","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1021\/jm070279v","article-title":"(Phenylpiperazinyl-butyl)oxindoles as selective 5-HT7 receptor antagonists","volume":"51","author":"Volk","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111705_bib48","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejmech.2014.01.055","article-title":"New 1-arylindoles based serotonin 5-HT7 antagonists. Synthesis and binding evaluation studies","volume":"75","author":"Sagnes","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111705_bib49","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1016\/j.bmc.2007.11.049","article-title":"Novel quinazolinone derivatives as 5-HT7 receptor ligands","volume":"16","author":"Na","year":"2008","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.111705_bib50","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ejmech.2014.01.065","article-title":"SAR-studies on the importance of aromatic ring topologies in search for selective 5-HT7 receptor ligands among phenylpiperazine hydantoin derivatives","volume":"78","author":"Handzlik","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111705_bib51","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejmech.2018.01.093","article-title":"Computer-aided insights into receptor-ligand interaction for novel 5-arylhydantoin derivatives as serotonin 5-HT7 receptor agents with antidepressant activity","volume":"147","author":"Kucwaj-Brysz","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111705_bib52","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1039\/C5MD00166H","article-title":"Arylsulfonamide derivatives of (aryloxy)ethylpiperidines as selective 5-HT7 receptor antagonists and their psychotropic properties","volume":"6","author":"Zajdel","year":"2015","journal-title":"Med. Chem. Comm."},{"key":"10.1016\/j.ejmech.2019.111705_bib53","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ejmech.2015.11.040","article-title":"Towards new 5-HT7 antagonists among arylsulfonamide derivatives of (aryloxy)ethyl-alkyl amines: multiobjective based design, synthesis, and anti-depressant and anxiolytic properties","volume":"108","author":"Canale","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111705_bib54","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ejmech.2012.07.043","article-title":"The multiobjective based design synthesis and evaluation of the arylsulfonamide\/amide derivatives of aryloxyethyl- and arylthioethyl- piperidines and pyrrolidines as a novel class of potent 5-HT7 receptor antagonists","volume":"56","author":"Zajdel","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111705_bib55","doi-asserted-by":"crossref","first-page":"8717","DOI":"10.1021\/acs.jmedchem.8b00828","article-title":"Amino acid hot spots of halogen bonding: a combined theoretical and experimental case study of the 5-HT7 receptor","volume":"61","author":"Kurczab","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111705_bib56","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.bmc.2015.11.041","article-title":"N-Alkylated arylsulfonamides of (aryloxy)ethyl piperidines: 5-HT7 receptor selectivity versus multireceptor profile","volume":"24","author":"Canale","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111705_bib57","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1016\/j.bmc.2017.03.057","article-title":"Novel 5-HT7R antagonists, arylsulfonamide derivatives of (aryloxy)propyl piperidines: add-on effect to the antidepressant activity of SSRI and DRI, and pro-cognitive profile","volume":"25","author":"Canale","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111705_bib58","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1021\/jm970519e","article-title":"N-dimethyl-N-[1-methyl-3-(4-methyl-piperidin-1-yl)propyl] benzenesulfonamide: the first selective 5-HT7 receptor antagonist","volume":"41","author":"Forbes","year":"1998","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111705_bib59","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1021\/jm991151j","article-title":"A\u00a0novel, potent, and selective 5-HT(7) antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl) phenol (SB-269970)","volume":"43","author":"Lovell","year":"2000","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111705_bib60","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1016\/S0960-894X(02)00690-X","article-title":"SB-656104-A: a novel 5-HT(7) receptor antagonist with improved in\u00a0vivo properties","volume":"12","author":"Forbes","year":"2002","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.111705_bib61","doi-asserted-by":"crossref","first-page":"5405","DOI":"10.1016\/j.bmc.2008.04.023","article-title":"Preparation of piperazine derivatives as 5-HT7 receptor antagonists","volume":"16","author":"Yoon","year":"2008","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.111705_bib62","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1016\/j.bmcl.2005.05.059","article-title":"Phenylpyrroles, a new chemolibrary virtual screening class of 5-HT7 receptor ligands","volume":"15","author":"Paillet-Loilier","year":"2005","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.111705_bib63","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1016\/j.bmcl.2007.03.054","article-title":"Novel aminoethylbiphenyls as 5-HT7 receptor ligands","volume":"17","author":"Paillet-Loilier","year":"2007","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.111705_bib64","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1016\/j.bmc.2013.02.038","article-title":"Discovery of aryl-biphenyl-2-ylmethylpiperazines as novel scaffolds for 5-HT(7) ligands and role of the aromatic substituents in binding to the target receptor","volume":"21","author":"Kim","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111705_bib65","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1002\/cmdc.201300240","article-title":"Aryl biphenyl-3-ylmethylpiperazines as 5-HT7 receptor antagonists","volume":"8","author":"Kim","year":"2013","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2019.111705_bib66","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1124\/jpet.112.193995","article-title":"Translational evaluation of JNJ-18038683, a 5-hydroxytryptamine type 7 receptor antagonist, on rapid eye movement sleep and in major depressive disorder","volume":"342","author":"Bonaventure","year":"2012","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2019.111705_bib67","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1016\/j.bmcl.2004.06.008","article-title":"Aminotriazine 5-HT7 antagonists","volume":"14","author":"Mattson","year":"2004","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.111705_bib68","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1016\/j.bmcl.2004.06.007","article-title":"Diaminopyrimidine and diaminopyridine 5-HT7 ligands","volume":"14","author":"Denhart","year":"2004","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.111705_bib69","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0960-894X(00)00166-9","article-title":"First pharmacophoric hypothesis for 5-HT7 antagonism","volume":"10","author":"L\u00f3pez-Rodr\u00edguez","year":"2000","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.111705_bib70","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1021\/ci030036l","article-title":"Molecular design based on 3D pharmacophores. Applications to 5-HT7 receptors","volume":"44","author":"Lepailleur","year":"2004","journal-title":"J.\u00a0Chem. Inf. Comput. Sci."},{"key":"10.1016\/j.ejmech.2019.111705_bib71","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1021\/ci050045p","article-title":"Molecular modeling studies focused on 5-HT7 versus 5-HT1A selectivity. Discovery of novel phenylpyrrole derivatives with high affinity for 5-HT7 receptors","volume":"45","author":"Lepailleur","year":"2005","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2019.111705_bib72","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1021\/jm070487n","article-title":"Structure-activity relationship study on N-(1, 2, 3, 4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinehexanamides, a class of 5-HT7 receptor agents","volume":"50","author":"Leopoldo","year":"2007","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111705_bib73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2010.06.036","article-title":"LP-211 is a brain penetrant selective agonist for the serotonin 5-HT7 receptor","volume":"481","author":"Hedlund","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejmech.2019.111705_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnbeh.2015.00065","article-title":"Novel agonists for serotonin 5-HT7 receptors reverse metabotropic glutamate receptor-mediated long-term depression in the hippocampus of wild-type and Fmr1 KO mice, a model of Fragile X Syndrome","volume":"9","author":"Costa","year":"2015","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.ejmech.2019.111705_bib75","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00221-013-3498-0","article-title":"Towards metabolically stable 5-HT7 receptor ligands: a study on 1-arylpiperazine derivatives and related isosters","volume":"230","author":"Lacivita","year":"2013","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.ejmech.2019.111705_bib76","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1016\/j.bmcl.2013.09.025","article-title":"Novel highly potent serotonin 5-HT7 receptor ligands: structural modifications to improve pharmacokinetic properties","volume":"23","author":"Lacivita","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.111705_bib77","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ejmech.2016.05.005","article-title":"Structural modifications of the serotonin 5-HT7 receptor agonist N-(4-cyanophenylmethyl)-4-(2-biphenyl)-1-piperazinehexanamide (LP-211) to improve in\u00a0vitro microsomal stability: a case study","volume":"120","author":"Lacivita","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111705_bib78","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.pain.2008.11.009","article-title":"5-HT7 receptor activation inhibits mechanical hypersensitivity secondary to capsaicin sensitization in mice","volume":"141","author":"Brenchat","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.ejmech.2019.111705_bib79","first-page":"7","article-title":"Low-basicity 5-HT7 receptor agonists synthesized using the van Leusen multicomponent protocol","author":"Hogendorf","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2019.111705_bib80","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ejmech.2019.03.017","article-title":"Fluorinated indole-imidazole conjugates: selective orally bioavailable 5-HT7 receptor low-basicity agonists, potential neuropathic painkillers","volume":"170","author":"Hogendorf","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111705_bib81","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.bmcl.2003.11.050","article-title":"Thiazoles and thiopyridines: novel series of high affinity 5HT(7) ligands","volume":"14","author":"Thomson","year":"2004","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.111705_bib82","first-page":"1","article-title":"Assessment of 5-HT7 receptor agonists selectivity using nociceptive and thermoregulation tests in knockout versus wild-type mice","author":"Brenchat","year":"2012","journal-title":"Adv. Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2019.111705_bib83","doi-asserted-by":"crossref","first-page":"6375","DOI":"10.1021\/jm3003679","article-title":"Investigations on the 1-(2-biphenyl)piperazine motif: identification of new potent and selective ligands for the serotonin 7 (5-HT7) receptor with agonist or antagonist action in\u00a0vitro or ex\u00a0vivo","volume":"55","author":"Lacivita","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111705_bib84","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.bmcl.2005.11.067","article-title":"Aminoalkyl phenyl sulfones-A novel series of 5-HT7 receptor ligands","volume":"16","author":"Raubo","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111705_bib85","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.1016\/j.bmcl.2016.06.080","article-title":"Design and synthesis of new homo and hetero bis-piperazinyl-1-propanone derivatives as 5-HT7R selective ligands over 5-HT1AR","volume":"26","author":"Intagliata","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.111705_bib86","doi-asserted-by":"crossref","first-page":"7218","DOI":"10.1021\/acs.jmedchem.8b00642","article-title":"Discovery of \u03b2-arrestin biased ligands of 5-HT7R","volume":"61","author":"Kim","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111705_bib87","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0165-3806(02)00550-3","article-title":"Serotonin regulates hippocampal glucocorticoid receptor expression via a 5-HT7 receptor","volume":"139","author":"Laplante","year":"2002","journal-title":"Brain Res. Dev. Brain Res."},{"key":"10.1016\/j.ejmech.2019.111705_bib88","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1046\/j.1471-4159.1997.68062604.x","article-title":"Down-regulation of 5-hydroxytryptamine7 receptors by dexamethasone in rat frontocortical astrocytes","volume":"68","author":"Shimizu","year":"1997","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.ejmech.2019.111705_bib89","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1046\/j.1365-2826.1999.00328.x","article-title":"Adrenocorticotropic hormone secretion in rats induced by stimulation with serotonergic compounds","volume":"11","author":"Jorgensen","year":"1999","journal-title":"J.\u00a0Neuroendocrinol."},{"key":"10.1016\/j.ejmech.2019.111705_bib90","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1139\/jpn.0421","article-title":"Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression","volume":"29","author":"Barden","year":"2003","journal-title":"J.\u00a0Psychiatry Neurosci."},{"key":"10.1016\/j.ejmech.2019.111705_bib91","doi-asserted-by":"crossref","first-page":"5351","DOI":"10.1523\/JNEUROSCI.21-14-05351.2001","article-title":"Vivo resetting of the hamster circadian clock by 5-HT7 receptors in the suprachiasmatic nucleus","volume":"21","author":"Ehlen","year":"2001","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ejmech.2019.111705_bib92","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.brainres.2004.02.025","article-title":"Aging and SB-269970-A, a selective 5-HT7 receptor antagonist, attenuate circadian phase advances induced by microinjections of serotonergic drugs in the hamster dorsal raphe nucleus","volume":"1008","author":"Duncan","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.ejmech.2019.111705_bib93","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2014.00453","article-title":"Selective pharmacological blockade of the 5-HT7 receptor attenuates light and 8-OH-DPAT induced phase shifts of mouse circadian wheel running activity","volume":"8","author":"Shelton","year":"2015","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.ejmech.2019.111705_bib94","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.neuropharm.2011.09.012","article-title":"Modulatory effects of two novel agonists for serotonin receptor 7 on emotion, motivation and circadian rhythm profiles in mice","volume":"62","author":"Adriani","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2019.111705_bib95","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.physbeh.2012.12.009","article-title":"The effects of combining serotonin reuptake inhibition and 5-HT7 receptor blockade on circadian rhythm regulation in rodents","volume":"110\u2013111","author":"Westrich","year":"2013","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ejmech.2019.111705_bib96","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1073\/pnas.0337340100","article-title":"No hypothermic response to serotonin in 5-HT7 receptor knockout mice","volume":"100","author":"Hedlund","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2019.111705_bib97","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.neulet.2006.05.023","article-title":"Effects of the 5-HT7 receptor antagonist SB-269970 on rat hormonal and temperature responses to the 5-HT1A\/7 receptor agonist 8-OH-DPAT","volume":"404","author":"Faure","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejmech.2019.111705_bib98","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/sj.bjp.0705290","article-title":"SB-656104-A, a novel selective 5-HT7 receptor antagonist, modulates REM sleep in rats","volume":"139","author":"Thomas","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.111705_bib99","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.bbr.2005.09.025","article-title":"Effects of the 5-HT7 receptor antagonist SB-269970 microinjected into the dorsal raphe nucleus on REM sleep in the rat","volume":"167","author":"Monti","year":"2006","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejmech.2019.111705_bib100","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.neuropharm.2008.09.014","article-title":"5-HT7 receptor deletion enhances REM sleep suppression induced by selective serotonin reuptake inhibitors, but not by direct stimulation of 5-HT1A receptor","volume":"56","author":"Shelton","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2019.111705_bib101","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1124\/jpet.107.119404","article-title":"Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents","volume":"321","author":"Bonaventure","year":"2007","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2019.111705_bib102","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.bbr.2008.03.025","article-title":"The serotonin 5-HT7 receptor agonist LP-44 microinjected into the dorsal raphe nucleus suppresses REM sleep in the rat","volume":"191","author":"Monti","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejmech.2019.111705_bib103","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.bbr.2013.11.030","article-title":"Systemic administration and local microinjection into the central nervous system of the 5-HT7 receptor agonist LP-211 modify the sleep-wake cycle in the rat","volume":"259","author":"Monti","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejmech.2019.111705_bib104","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0301-0082(00)00018-6","article-title":"Elucidation of the neurobiology of depression: insights from a novel genetic animal model","volume":"62","author":"Yadid","year":"2000","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejmech.2019.111705_bib105","series-title":"Sleep Disturbances in Patients with Schizophrenia: Impact and Effect of Antipsychotics","first-page":"939","volume":"22","author":"Cohrs","year":"2008"},{"key":"10.1016\/j.ejmech.2019.111705_bib106","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0022-3565(25)38596-4","article-title":"Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors","volume":"268","author":"Roth","year":"1994","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2019.111705_bib107","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0893-133X(99)00041-X","article-title":"Effects of Antidepressants on 5-HT7 Receptor Regulation in the Rat Hypothalamus","volume":"vol. 21","author":"Mullins","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejmech.2019.111705_bib108","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0304-3940(01)02054-7","article-title":"Acute restraint stress increases 5-HT7 receptor mRNA expression in the rat hippocampus","volume":"309","author":"Yau","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejmech.2019.111705_bib109","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1016\/j.neulet.2006.12.054","article-title":"The 5-HT7 receptor influences stereotypic behavior in a model of obsessive-compulsive disorder","volume":"414","author":"Hedlund","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejmech.2019.111705_bib110","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.neuropharm.2006.04.017","article-title":"Effect of the selective 5-HT(7) receptor antagonist SB 269970 in animal models of anxiety and depression","volume":"51","author":"Wesolowska","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2019.111705_bib111","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jpsychires.2006.06.011","article-title":"Hippocampal volume reduction and HPA-system activity in major depression","volume":"41","author":"Colla","year":"2007","journal-title":"J.\u00a0Psychol. Res."},{"key":"10.1016\/j.ejmech.2019.111705_bib112","doi-asserted-by":"crossref","first-page":"9104","DOI":"10.1523\/JNEUROSCI.20-24-09104.2000","article-title":"Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus","volume":"20","author":"Malberg","year":"2000","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ejmech.2019.111705_bib113","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1440-1681.2007.04608.x","article-title":"Neurogenesis and antidepressants: a promising therapeutic axis for treating depression","volume":"34","author":"Nandam","year":"2007","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ejmech.2019.111705_bib114","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.bbr.2010.01.022","article-title":"The 5-HT(7) receptor as a mediator and modulator of antidepressant-like behavior","volume":"209","author":"Sarkisyan","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejmech.2019.111705_bib115","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejphar.2006.10.001","article-title":"Enhancement of the anti-immobility action of antidepressants by a selective 5-HT7 receptor antagonist in the forced swimming test in mice","volume":"555","author":"Wesolowska","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.111705_bib116","first-page":"464","article-title":"Influence of serotonin 5-HT(7) receptor blockade on the behavioral and neurochemical effects of imipramine in rats","volume":"60","author":"Wesolowska","year":"2008","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejmech.2019.111705_bib117","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.biopsych.2006.12.011","article-title":"Inactivation of the 5-HT(7) receptor partially blocks phencyclidine-induced disruption of prepulse inhibition","volume":"63","author":"Semenova","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejmech.2019.111705_bib118","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0091-3057(01)00744-4","article-title":"Effects of the 5-HT(7) receptor antagonist SB-258741 in animal models for schizophrenia","volume":"71","author":"Pouzet","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejmech.2019.111705_bib119","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/sj.npp.1300901","article-title":"Positive association of the serotonin 5-HT7 receptor gene with schizophrenia in a Japanese population","volume":"31","author":"Ikeda","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejmech.2019.111705_bib120","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.neulet.2004.01.072","article-title":"Selective 5-HT(1A) and 5-HT(7) antagonists decrease epileptic activity in the WAG\/Rij rat model of absence epilepsy","volume":"359","author":"Graf","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejmech.2019.111705_bib121","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.eplepsyres.2007.03.017","article-title":"Constitutive Deletion of the Serotonin-7 (5-HT(7)) Receptor Decreases Electrical and Chemical Seizure Thresholds","volume":"75","author":"Witkin","year":"2007","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejmech.2019.111705_bib122","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.brainres.2007.01.019","article-title":"The role of 5-HT7 receptors in the control of seizures","volume":"1141","author":"Pericic","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.ejmech.2019.111705_bib123","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1523\/JNEUROSCI.5113-03.2004","article-title":"Serotonergic regulation of membrane potential in developing rat prefrontal cortex: coordinated expression of 5-hydroxytryptamine (5-HT)1A, 5-HT2A, and 5-HT7 receptors","volume":"24","author":"B\u00e9\u00efque","year":"2004","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ejmech.2019.111705_bib124","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.devbrainres.2004.11.002","article-title":"In\u00a0vitropostnatal expression of 5-HT7 receptors in the rat hypothalamus: an immunohistochemical analysis","volume":"154","author":"Russo","year":"2005","journal-title":"Brain Res. Dev. Brain Res."},{"key":"10.1016\/j.ejmech.2019.111705_bib125","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1152\/jn.00543.2003","article-title":"Opposing electrophysiological actions of 5-HT on non-cholinergic and cholinergic neurons in the rat ventral pallidum in\u00a0vitro","volume":"92","author":"Bengtson","year":"2004","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.ejmech.2019.111705_bib126","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1111\/j.1460-9568.2004.03288.x","article-title":"Mice lacking 5-HT7 receptors show specific impairments in contextual learning","volume":"19","author":"Roberts","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejmech.2019.111705_bib127","series-title":"Overexpression of hAPPswe Impairs Rewarded Alternation and Contextual Fear Conditioning in a Transgenic Mouse Model of Alzheimer's Disease","first-page":"243","volume":"vol. 9","author":"Corcoran","year":"2002"},{"key":"10.1016\/j.ejmech.2019.111705_bib128","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.bbr.2004.04.026","article-title":"Effects of the 5-HT7 receptor antagonists SB-269970 and DR 4004 in autoshaping Pavlovian\/instrumental learning task","volume":"155","author":"Meneses","year":"2004","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejmech.2019.111705_bib129","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bbr.2013.01.026","article-title":"The role of 5-HT7 receptor antagonism in the amelioration of MK-801-induced learning and memory deficits by the novel atypical antipsychotic drug lurasidone","volume":"244","author":"Horisawa","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejmech.2019.111705_bib130","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bbr.2005.04.014","article-title":"Effects of the potential 5-HT7 receptor agonist AS-19 in an autoshaping learning task","volume":"163","author":"Perez-Garcia","year":"2005","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejmech.2019.111705_bib131","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1152\/jn.01181.2003","article-title":"Modulation of locomotor activity by multiple 5-HT and dopaminergic receptor subtypes in the neonatal mouse spinal cord","volume":"92","author":"Madriaga","year":"2004","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.ejmech.2019.111705_bib132","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.brainresrev.2007.07.019","article-title":"Descending command systems for the initiation of locomotion in mammals","volume":"57","author":"Jordan","year":"2008","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.ejmech.2019.111705_bib133","first-page":"25","article-title":"Intraspinal grafting of serotonergic neurons modifies expression of genes important for functional recovery in paraplegic rats","author":"Miazga","year":"2018","journal-title":"Neural Plast."},{"key":"10.1016\/j.ejmech.2019.111705_bib134","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1152\/jn.91239.2008","article-title":"Spinal 5-HT7 receptors are critical for alternating activity during locomotion: in\u00a0vitro neonatal and in\u00a0vivo adult studies using 5-HT7 receptor knockout mice","volume":"102","author":"Liu","year":"2009","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.ejmech.2019.111705_bib135","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1113\/JP272271","article-title":"Serotonin controls initiation of locomotion and afferent modulation of coordination via 5-HT7 receptors in adult rats","volume":"595","author":"Cabaj","year":"2017","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.ejmech.2019.111705_bib136","doi-asserted-by":"crossref","first-page":"5469","DOI":"10.1113\/jphysiol.2009.176982","article-title":"Episodic spinal serotonin receptor activation elicits long-lasting phrenic motor facilitation by an NADPH oxidase-dependent mechanism","volume":"587","author":"MacFarlane","year":"2009","journal-title":"J.\u00a0Physiol. (London)"},{"key":"10.1016\/j.ejmech.2019.111705_bib137","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/sj.bjp.0702580","article-title":"Pharmacological evidence for the 5-HT7 receptor mediating smooth muscle relaxation in canine cerebral artery","volume":"127","author":"Terron","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.111705_bib138","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejphar.2007.01.019","article-title":"5-HT7 receptor-mediated dilatation in the middle meningeal artery of anesthetized rats","volume":"560","author":"Terron","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.111705_bib139","series-title":"Pronociceptive Role of Peripheral and Spinal 5-HT7 Receptors in the Formalin Test","first-page":"182","volume":"117","author":"Rocha-Gonzalez","year":"2005"},{"key":"10.1016\/j.ejmech.2019.111705_bib140","series-title":"Activation of 5-HT1A and 5-HT7 Receptors in the Parafascicular Nucleus Suppresses the Affective Reaction of Rats to Noxious Stimulation","first-page":"405","volume":"113","author":"Harte","year":"2005"},{"key":"10.1016\/j.ejmech.2019.111705_bib141","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejpain.2011.07.004","article-title":"Role of peripheral versus spinal 5-HT7 receptors in the modulation of pain undersensitizing conditions","volume":"16","author":"Brenchat","year":"2012","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.ejmech.2019.111705_bib142","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.nbd.2017.07.005","article-title":"The brain-penetrant 5-HT7 receptor agonist LP-211 reduces the sensory and affective components of neuropathic pain","volume":"106","author":"Santello","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejmech.2019.111705_bib143","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejphar.2013.01.074","article-title":"Pharmacology of Pain. Multiple roles of serotonin in pain control mechanisms \u2014implications of 5-HT7 and other 5-HT receptor types","volume":"716","author":"Viguiera","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.111705_bib144","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.neuroscience.2007.07.043","article-title":"The 5-HT7 receptor: role in novel object discrimination and relation to novelty-seeking behavior","volume":"149","author":"Ballaz","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejmech.2019.111705_bib145","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1601-183X.2009.00486.x","article-title":"Methylphenidate to adolescent rats drives enduring changes of accumbal Htr7 expression: implications for impulsive behavior and neuronal morphology","volume":"8","author":"Leo","year":"2009","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.ejmech.2019.111705_bib146","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bbr.2009.03.011","article-title":"The 5-HT7 receptor is involved in allocentric spatial memory information processing","volume":"202","author":"Sarkisyan","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejmech.2019.111705_bib147","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/ajmg.b.31136","article-title":"Genome-wide association study of theta band event-related oscillations identifies serotonin receptor gene HTR7 influencing risk of alcohol dependence","volume":"156","author":"Zlojutro","year":"2011","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.ejmech.2019.111705_bib148","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1111\/j.1460-9568.2012.08037.x","article-title":"Serotonin2C receptors in the nucleus accumbens are involved in enhanced alcohol-drinking behavior","volume":"35","author":"Yoshimoto","year":"2012","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejmech.2019.111705_bib149","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.resp.2005.09.003","article-title":"Serotoninergic receptors in the anteroventral preoptic region modulate the hypoxic ventilator response","volume":"153","author":"Gargaglioni","year":"2006","journal-title":"Respir. Physiol. Neurobiol."},{"key":"10.1016\/j.ejmech.2019.111705_bib150","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.neuroscience.2013.06.068","article-title":"Spinal 5-HT7 receptors and protein kinase a constrain intermittent hypoxia-induced phrenic long-term facilitation","volume":"250","author":"Hoffman","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejmech.2019.111705_bib151","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.imbio.2013.04.012","article-title":"Peripheral 5-HT7 receptors as a new target for prevention of lung injury and mortality in septic rats","volume":"218","author":"Cadirci","year":"2013","journal-title":"Immunobiology"},{"key":"10.1016\/j.ejmech.2019.111705_bib152","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s10528-016-9769-2","article-title":"Evaluation of 5-HT7 receptor trafficking on in\u00a0vivo and in\u00a0vitro model of lipopolysaccharide (LPS)-induced inflammatory cell injury in rats and LPS-treated A549 cells","volume":"55","author":"Ayaz","year":"2017","journal-title":"Biochem. Genet."},{"key":"10.1016\/j.ejmech.2019.111705_bib153","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejphar.2017.08.014","article-title":"5-HT7 receptor antagonism (SB-269970) attenuates bleomycin-induced pulmonary fibrosis in rats via downregulating oxidative burden and inflammatory cascades and ameliorating collagen deposition: comparison to terguride","volume":"814","author":"Tawfik","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.111705_bib154","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.resp.2015.11.018","article-title":"Allergic sensitization modifies the pulmonary expression of 5-hydroxytryptamine receptors in Guinea pigs","volume":"223","author":"Cordoba-Rodriguez","year":"2017","journal-title":"Respir. Physiol. Neurobiol."},{"key":"10.1016\/j.ejmech.2019.111705_bib155","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.brainres.2007.01.088","article-title":"Involvement of central 5-HT7 receptors in modulation of cardiovascular reflexes in awake rats","volume":"1144","author":"Damaso","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.ejmech.2019.111705_bib156","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1113\/jphysiol.2004.076521","article-title":"Central 5-HT7 receptors are critical for reflex activation of cardiac vagal drive in anaesthetized rats","volume":"563","author":"Kellett","year":"2005","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.ejmech.2019.111705_bib157","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00210-004-1006-6","article-title":"Evidence for 5-HT2B and 5-HT7 receptor-mediated relaxation in pulmonary arteries of weaned pigs","volume":"371","author":"Jahnichen","year":"2005","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.111705_bib158","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/sj.bjp.0701260","article-title":"Characterization of putative 5-HT7 receptors mediating tachycardia in the cat","volume":"121","author":"Villalon","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.111705_bib159","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejphar.2014.08.027","article-title":"Activation of serotonin 5-HT7 receptor iduces coronary flow increase in isolated rat heart","volume":"748","author":"Chang Chien","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.111705_bib160","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ejphar.2004.08.050","article-title":"5-HT7, but not 5-HT2B receptors mediate hypotension in vagosympathectomized rats","volume":"502","author":"Centurion","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.111705_bib161","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/FJC.0000000000000433","article-title":"Chronic sarpogrelate treatment reveals 5-HT7 receptor in the serotonergic inhibition of the rat vagal bradycardia","volume":"69","author":"Garc\u00eda-Pedraza","year":"2017","journal-title":"J.\u00a0Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.111705_bib162","doi-asserted-by":"crossref","first-page":"H676","DOI":"10.1152\/ajpheart.00165.2017","article-title":"5-HT causes splanchnic venodilation","volume":"313","author":"Seitz","year":"2017","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejmech.2019.111705_bib163","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.vph.2014.06.009","article-title":"Role of 5-HT7 receptors in the inhibition of the vasodepressor sensory CGRPergic outflow in pithed rats","volume":"63","author":"Cuesta","year":"2014","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.111705_bib164","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2014.08.003","article-title":"Serotonin and sensory nerves: meeting in the cardiovascular system","volume":"63","author":"Watts","year":"2014","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.111705_bib165","doi-asserted-by":"crossref","first-page":"G144","DOI":"10.1152\/ajpgi.00496.2009","article-title":"Critical role of 5-HT1A, 5-HT3, and 5-HT7 receptor subtypes in the initiation, generation, and propagation of the murine colonic migrating motor complex","volume":"299","author":"Dickson","year":"2010","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.ejmech.2019.111705_bib166","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/sj.bjp.0702762","article-title":"Evidence for 5-HT7 receptors mediating relaxation of human colonic circular smooth muscle","volume":"128","author":"Prins","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.111705_bib167","first-page":"8","article-title":"5-HT7 receptor signaling: improved therapeutic strategy in gut disorders","author":"Kim","year":"2014","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.ejmech.2019.111705_bib168","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.4049\/jimmunol.1201887","article-title":"Targeted inhibition of serotonin type 7 (5-HT7) receptor function modulates immune responses and reduced the severity of intestinal inflammation","volume":"190","author":"Kim","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ejmech.2019.111705_bib169","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1097\/MIB.0000000000000150","article-title":"Serotonin 5-HT7 receptor is critically involved in acute and chronic inflammation of the gastrointestinal tract","volume":"20","author":"Guseva","year":"2014","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.ejmech.2019.111705_bib170","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1476-5381.2009.00144.x","article-title":"5-hydroxytryptamine induced relaxation in the pig urinary bladder neck","volume":"157","author":"Recio","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.111705_bib171","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ejphar.2010.10.027","article-title":"5-hydroxytryptamine potentiates neurogenic contractions of rat isolated urinary bladder through both 5-HT7 and 5-HT2c receptors","volume":"650","author":"Rekik","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.111705_bib172","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1111\/j.1464-410X.2004.05114.x","article-title":"Involvement of 5-hydroxytryptamine (HT)7 receptors in the 5-HT excitatory effects on the rat urinary bladder","volume":"94","author":"Palea","year":"2004","journal-title":"BJU Int."},{"key":"10.1016\/j.ejmech.2019.111705_bib173","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/sj.bjp.0705399","article-title":"Evidence for the involvement of central 5-HT7 receptors in the micturition reflex in anaesthetized female rats","volume":"140","author":"Read","year":"2003","journal-title":"Br. J. Pharmacol."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.ejmech.2019.111705_bib174","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s12325-015-0242-0","article-title":"Expression of 5-hydroxytryptamine receptors in human urinary bladders with benign prostatic hyperplasia","volume":"32","author":"Imamura","year":"2015","journal-title":"Adv. Ther."},{"key":"10.1016\/j.ejmech.2019.111705_bib175","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1111\/bph.13941","article-title":"Brain serotoninergic nervous system is involved in bombesin-induced frequent urination through brain 5-HT7 receptors in rats","volume":"174","author":"Shimizu","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.111705_bib176","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/nau.22463","article-title":"The effect of the 5-HT7 serotonin receptor agonist, LP-44, on micturition in rats with chronic spinal cord injury","volume":"33","author":"Gang","year":"2014","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.ejmech.2019.111705_bib177","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1146\/annurev-animal-022513-114227","article-title":"Serotonin: a local regulator in the mammary gland epithelium","volume":"2","author":"Horseman","year":"2014","journal-title":"Annu. Rev. Anim. Biosci."},{"key":"10.1016\/j.ejmech.2019.111705_bib178","doi-asserted-by":"crossref","DOI":"10.1186\/bcr2448","article-title":"Altered serotonin physiology in human breast cancers favors paradoxical growth and cell survival","volume":"11","author":"Pai","year":"2009","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.ejmech.2019.111705_bib179","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-016-0559-6","article-title":"Trytophan hydroxylase 1 and 5-HT7 receptor preferentially expressed in triple-negative breast cancer promote cancer progression through autocrine serotonin signaling","volume":"15","author":"Gautam","year":"2016","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ejmech.2019.111705_bib180","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10549-016-4027-1","article-title":"Up-regulation of Cathepsin S expression by HSP90 and 5-HT7 receptor-dependent serotonin signaling correlates with triple negativity of human breast cancer","volume":"161","author":"Gautam","year":"2017","journal-title":"Breast Canc. Res. Treat."},{"key":"10.1016\/j.ejmech.2019.111705_bib181","doi-asserted-by":"crossref","DOI":"10.1186\/s12876-014-0201-2","article-title":"Effect of 5-HT7 receptor blockade on liver regeneration after 60\u221270% partial hepatectomy","volume":"14","author":"Tzirogiannis","year":"2014","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.ejmech.2019.111705_bib182","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/cas.12174","article-title":"Serotonin and the 5-HT7 receptor: the link between hepatocytes, IGF-1 and small intestinal neuroendocrine tumors","volume":"104","author":"Svejda","year":"2013","journal-title":"Cancer Sci."},{"key":"10.1016\/j.ejmech.2019.111705_bib183","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.molonc.2015.09.008","article-title":"5-Hydroxytryptamine promotes hepatocellular carcinoma proliferation by influencing \u03b2-catenin","volume":"10","author":"Fatima","year":"2016","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.ejmech.2019.111705_bib184","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.intimp.2016.12.023","article-title":"Liver 5-HT7 receptors: a novel regulator target of fibrosis and inflammation-induced chronic liver injury in\u00a0vivo and in\u00a0vitro","volume":"43","author":"Polat","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejmech.2019.111705_bib185","series-title":"Clinical Trials.Gov","author":"U.S. National Library of Medicine","year":"2019"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419308578?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419308578?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:08:23Z","timestamp":1759327703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523419308578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":185,"alternative-id":["S0223523419308578"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.111705","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-activity relationships of serotonin 5-HT7 receptors ligands: A review","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.111705","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111705"}}